Home/Filings/4/0001735276-22-000069
4//SEC Filing

SHARP PHILLIP A 4

Accession 0001735276-22-000069

CIK 0001178670other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 4:07 PM ET

Size

20.5 KB

Accession

0001735276-22-000069

Insider Transaction Report

Form 4
Period: 2022-08-15
Transactions
  • Sale

    Common Stock

    2022-08-15$232.81/sh715$166,4590 total
  • Exercise/Conversion

    Common Stock

    2022-08-15$30.09/sh+30,000$902,70030,000 total
  • Sale

    Common Stock

    2022-08-15$226.16/sh98$22,16433,572 total
  • Sale

    Common Stock

    2022-08-15$228.33/sh1,218$278,10632,354 total
  • Sale

    Common Stock

    2022-08-15$231.65/sh3,853$892,547715 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-08-1530,0000 total
    Exercise: $30.09From: 2014-06-06Exp: 2023-06-06Common Stock (30,000 underlying)
  • Sale

    Common Stock

    2022-08-15$230.71/sh16,186$3,734,2724,568 total
  • Exercise/Conversion

    Common Stock

    2022-08-15$63.86/sh+3,670$234,36633,670 total
  • Sale

    Common Stock

    2022-08-15$229.93/sh11,600$2,667,18820,754 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-08-153,6700 total
    Exercise: $63.86Exp: 2024-01-02Common Stock (3,670 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    266,899
Footnotes (8)
  • [F1]The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022.
  • [F2]Sale prices ranged from $228.00 to $228.80.
  • [F3]Sale prices ranged from $229.29 to $230.29.
  • [F4]Sale prices ranged from $230.30 to $231.30.
  • [F5]Sale prices ranged from $231.31 to $232.26.
  • [F6]Sale prices ranged from $232.53 to $233.16.
  • [F7]Includes shares held by the Phillip A. Sharp Revocable Trust, of which the reporting person and his spouse are co-trustees. Also includes shares held in trust for the benefit of the reporting persons children, of which the reporting persons children and spouse are the trustees.
  • [F8]The stock option was fully vested as of 12/31/14.

Issuer

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670

Entity typeother
IncorporatedMA

Related Parties

1
  • filerCIK 0001226295

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:07 PM ET
Size
20.5 KB